Baklava is a modern hybrid-indica strain derived from the genetics of Gelato. As a stable crossbreed, it represents a contemporary approach to cannabis cultivation, designed to balance specific traits inherited from its lineage. The plant is rated as being of moderate difficulty for cultivators, requiring a standard 63-day flowering period to reach maturity. It is well-suited for both indoor and outdoor environments, consistently providing high yields for those who manage its requirements effectively.

The chemical profile of Baklava is characterized by a prominent presence of limonene, followed by caryophyllene, myrcene, linalool, and humulene. This terpene hierarchy creates a distinct sensory experience that reflects its specific botanical composition. The dominant limonene provides a bright, citrus-forward foundation that is rounded out by the spicy, peppery depth of caryophyllene and the earthy, herbal undertones of myrcene. The inclusion of linalool and humulene adds a subtle complexity to the final aromatic and flavor profile.

With a THC content measured at approximately 20.9 percent, Baklava produces potent, targeted effects that leave the user feeling both relaxed and focused. This combination of mental clarity and physical ease makes it a functional choice for addressing pain, stress, or difficulty achieving sleep. While it has established itself as an effective tool for therapeutic use, it currently has no recorded offspring in the registry of notable cannabis varieties.